Inhibition of human immunodeficiency virus gene amplification by heparin

Mark Holodniy, Su Yeon Kim, David Katzenstein, +3

Journal of Clinical Microbiology

Acid Citrate DextroseGene AmplificationBiochemistryMedicineHuman Retrovirus +13

Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections

John Nemunaitis, Meyers Jd, CD Buckner, +7

Blood

Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

Louis M. Weiner, Joyce L. O'Dwyer, J Kitson, +5

PubMed

Breast OncologyImmunologyImmunotherapeuticsPharmacotherapyImmunotherapy +14

Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies

B J Gould, Michael J. Borowitz, Eric S. Groves, +4

JNCI Journal of the National Cancer Institute

Fluid OverloadBreast OncologyImmunotoxicologyImmunologyImmunoediting +20

Intraventricular Immunotoxin Therapy for Leptomeningeal Neoplasia

Douglas W. Laske, Karin M. Muraszko, Edward H. Oldfield, +11

Neurosurgery

Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a phase II study

Ding‐Jen Lee, Andy Trotti, Sharon A. Spencer, +5

International Journal of Radiation Oncology*Biology*Physics

Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens.

Eric S. Groves, Alfred Singer

The Journal of Experimental Medicine

HistocompatibilityHla ImmunogeneticsImmunologyAntigen ProcessingImmunotherapy +15

Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody.

Pilar Pérez, J A Titus, M T Lotze, +6

The Journal of Immunology

ImmunologyAntigen ProcessingImmune Cell TherapyT CellsImmunotherapy +17

Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3

Robert Buckman, Carlo DeAngelis, Patricia Shaw, +11

Gynecologic Oncology

Breast OncologyMalignant AscitesMedicineMonoclonal Antibody 2G3Pathology +7

Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.

L A Matis, S Shu, Eric S. Groves, +5

The Journal of Immunology

Radiation OncologyIl 2Cell TherapyCancer ImmunosurveillanceTumor Growth +12